Brain regions from patients with or without Alzheimer disease (AD) were obtained within 2 hr of death and examined for indices of presynaptic cholinergic function. Consistent with loss of cholinergic projections, cerebral cortical areas involved in AD exhibited decreased choline acetyltransferase (acetyl-CoA:choline O-acetyltransferase, EC 2.3.1.6) activity. However, remaining nerve terminals in these regions displayed marked up-regulation of synaptosomal high affinity [3Hlcholine uptake, a result indicative of relative cholinergic hyperactivity. As choline uptake is also rate-limiting in acetylcholine biosynthesis, these rmdings have implications for both therapy and identification of causes contributing to neuronal death in AD.
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Alzheimer disease (AD), the leading cause of dementia and currently the fourth leading cause of death in the United States (1) , is characterized by the abnormal presence of senile plaques and neurofibrillary tangles in the central nervous system. Neurochemically, the loss of cholinergic projections to the cerebral cortex is the hallmark characteristic ofAD and has served as a focus for studies of its etiology and therapy (2) (3) (4) (5) (6) (7) (8) (9) . Dietary supplementation with neurotransmitter precursors represents a useful approach to the management of neurodegenerative diseases. The most prominent example is Parkinson disease, in which many ofthe symptoms ofdopaminergic deficiency can be offset with L-dopa (10) . In contrast, choline supplementation has proven to be only marginally successful in treating AD (2) (3) (4) (5) (6) (7) (8) (9) , suggesting either that cholinergic presynaptic function may be affected over and above the loss of terminals or, alternatively, that the clinical dementia is not due solely to cholinergic dysfunction (11) (12) (13) .
Acetylcholine synthesis proceeds via the active, highaffinity uptake of choline by the nerve terminal and subsequent conversion to acetylcholine by the enzyme choline acetyltransferase (ChAT; acetyl-CoA:choline O-acetyltransferase, EC 2.3.1.6). The uptake step is particularly important in that it is both rate-limiting and subject to regulation by neuronal impulse activity (14) (15) (16) . However, this step has not generally been evaluated in studies with human tissues because fresh material is required to isolate viable nerve terminal particles (synaptosomes) that will maintain their uptake characteristics; the up-regulation of choline uptake associated with neural stimulation decays particularly rapidly postmortem (17, 18 (19, 20) .
To meet the criteria for rapid autopsy, the postmortem delay from the time of death to chilling of tissues in ice-cold sucrose was under 2 hr (range, 30-112 min) and did not differ in the AD group (57 ± 2 min) compared to the non-AD group (63 ± 7 min). Approximately 1 ml ofgray matter was removed from the superior frontal gyrus, the superior parietal lobule, the superior temporal gyrus, the occipital cortex (Brodmann's area 17), caudate, putamen, and rostral hippocampal formation. Adjacent sections from each neocortical area were submitted for histologic analysis. Paraffin sections were stained with hematoxylin and eosin with a Luxol fast blue counterstain for myelin, a silver stain for neuritic plaques and neurofibrillary tangles (21) , and a Congo red stain for amyloid. Plaques and tangles were counted in three microscopic fields in each cortical and hippocampal section and are expressed as plaques or tangles per mm2. The histologic diagnosis of AD met the criteria proposed by Khachaturian (22) and other diagnoses were made according to customary neuropathologic criteria (23) . As examples of the clear delineation of the AD vs. non-AD populations, the AD group exhibited 50 ± 4 (mean ± SE) and 38 ± 4 plaques per mm2 in frontal and temporal cortex, respectively, whereas the non-AD group had only 2 ± 2 and 1 1 (P < 0.0001); tangles per mm2 in the AD group were 4.5 1.3 and 14 ± 4 in the same two cortical regions but were not detected (0 ± 0) in the non-AD group (P < 0.002).
Tissue Preparation and Biochemical Determinations. An aliquot was removed and diluted 1:3 for assessment of ChAT activity (24) and the P2 synaptosome fraction (25) standard preparation of adult rat cerebral cortex run concurrently with each set of patient samples; in addition, protein was measured in the P2 fraction to confirm consistent recovery of synaptosomes. Data Evaluation and Statistics. Data are reported as means and standard errors. All variables were first subjected to a two-way analysis of variance (ANOVA; factors of diagnostic category and region); however, the global test revealed that data could be separated into neocortical regions (frontal, parietal, temporal, and occipital cortex) vs. areas less (hippocampus, caudate) or least (putamen) affected by AD (27) (28) (29) . Where differences related to diagnosis (main effect or interaction of diagnosis and region) were identified, the ANOVA was then repeated with separation into neocortical vs. other regions; if diagnosis-region interactions were still detected, individual regions were evaluated for differences in the AD vs. non-AD group by Duncan's multiple range test. For all tests, significance was assumed at the level of P < 0.05.
RESULTS AND DISCUSSION
In keeping with biochemical and histological assessments of material obtained after more prolonged postmortem delays (2-9), examination of ChAT activity after rapid autopsy confirmed a significant deficit in the enzyme in AD patients, with the effect confined to neocortical regions (Fig. 1) . Notably, [3H]choline uptake into cortical synaptosomes was not decreased in AD. In fact, values tended to be elevated relative to the non-AD group (0.05 < P < 0.10), with the lack of statistical significance attributable to relatively large variability. The uptake/ChAT ratio was significantly elevated only in cortical regions; it was below that of non-AD patients elsewhere. Some of the variability in enzyme activity and uptake probably results from individual patient differences in the proximate cause of death, length of the agonal state, age, and premortem medication history. Accordingly, we corrected the values by using putamen as an internal standard, since this region contained the highest enzyme activity and uptake, does not display activity-related changes in uptake (14) (15) (16) , and is thought to be relatively uninvolved in AD (27, 28) ; although the caudate may be also relatively spared for cholinergic deficits in AD, there is some evidence for neuronal damage, which precludes considering it a "control" region (29) . As shown in Fig. 2 
